
Keeping children healthy through the gift of immunity. Immunity influences almost every medical illness. Through scientific discovery and innovation, we will harness the power of the immune system to prevent, treat or cure life-threatening childhood diseases.
Under the leadership of Dr. David Rawlings, the Center for Immunity and Immunotherapies aspires to: improve diagnosis of primary immune deficiencies and autoimmune diseases (such as arthritis, lupus and diabetes); advance gene therapy and gene repair as potential cures for target genetic disorders; identify vaccine strategies for immunologically vulnerable populations; and enhance immune monitoring techniques for autoimmune diseases, organ transplantation, infections, cancer and allergies.
The Northwest Genome Engineering Consortium (NGEC) brings together researchers at Seattle Children's Hospital Research Institute, Fred Hutchinson Cancer Research Center and the University of Washington to develop new methods for gene repair, an innovative approach to gene therapy. Dr. Andy Scharenberg and Dr. David Rawlings, members of the Center for Immunity and Immunotherapies, serve as NGEC co-directors and principal investigators.
The center also hosts the Flow Cytometry Core facility, which provides access to state-of-the-art cell sorters, analyzers, and workstations; training and technical support of investigators; assistance with experimental design, data analysis and interpretation; and assistance in developing novel flow cytometric bead-based techniques.
To achieve our vision we will:
To learn more about becoming a Member in this center, interested faculty and postdoctoral researchers are encouraged to contact David Rawlings, MD, at (206) 987-7450.